Considerations for analgosedation and antithrombotic management during extracorporeal life support.

about

Considerations for analgosedation and antithrombotic management during extracorporeal life support.

Item

http://www.wikidata.org/entity/Q39169651

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Considerations for analgosedat ...... g extracorporeal life support.

@en

Considerations for analgosedat ...... g extracorporeal life support.

@nl

type

Item

label

Considerations for analgosedat ...... g extracorporeal life support.

@en

Considerations for analgosedat ...... g extracorporeal life support.

@nl

prefLabel

Considerations for analgosedat ...... g extracorporeal life support.

@en

Considerations for analgosedat ...... g extracorporeal life support.

@nl

P1476

Considerations for analgosedat ...... ng extracorporeal life support

@en

P2093

Alan J Rozycki

http://www.w3.org/2001/XMLSchema#string

Pamela K Burcham

http://www.w3.org/2001/XMLSchema#string

P2860

TEG and ROTEM: technology and clinical applications

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism

Effect of renal function on the pharmacodynamics of argatroban.

Argatroban in extracorporeal membrane oxygenation.

Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.

Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.

Development and implementation of a nurse-driven, sliding-scale nomogram for bivalirudin in the management of heparin-induced thrombocytopenia.

Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.

Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites.

The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/ATM.2016.11.45

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erik E Abel

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28275614

http://www.w3.org/2001/XMLSchema#string

P921

extracorporeal membrane oxygenation

P932

5337214

http://www.w3.org/2001/XMLSchema#string